Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...

President Donald Trump is keeping up the pace with seemingly a new tariff development every day. This time, he flagged that ...

Johnson and Johnson beat Wall Street’s quarterly sales expectations and raised its full-year outlook, a show of confidence as ...

W hen Donald Trump’s tariffs are mentioned, you might recall his “Liberation Day” duties on uninhabited islands, his on-again ...

Johnson & Johnson (NYSE:JNJ) is set to kick off the second quarter pharma earnings on Wednesday, with investors focusing on ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...

Drugmaker Swedish Orphan Biovitrum AB’s Chief Executive Officer Guido Oelkers said he doesn’t think tariff threats on the ...

Already late with carrying out his administration's prior threats around pharmaceutical tariffs, President Donald Trump has ...

A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.

President Trump wants to place a 200 percent tariff on your pharmaceuticals. “We’ll be announcing something very soon on ...

President Trump threatened as much as 200% tariffs on pharma Tuesday. By Wednesday morning, Wall Street had ignored the ...

U.S. President Donald Trump on Tuesday indicated that the United States is likely to impose tariffs on imported ...